Department of Transplantation Medicine, Nephrology and Internal Medicine, Medical University of Warsaw, Nowogrodzka 59, 02-006, Warsaw, Poland.
Department of General and Transplantation Surgery, Medical University of Warsaw, Warsaw, Poland.
BMC Pregnancy Childbirth. 2021 Sep 16;21(1):627. doi: 10.1186/s12884-021-04104-w.
Liver transplantation is a life-saving and successful therapeutic procedure which is more and more frequent worldwide, also among women of reproductive age. Consequently, there is an increasing number of reports of pregnancy following liver transplantation, but doubts still exist regarding preconception counseling and the optimal method of managing pregnancy. The aim of this study was to report and evaluate pregnancy outcomes in women who had undergone liver transplantation.
We retrospectively analyzed female patients after orthotopic liver transplantation who reported pregnancy and were under medical care of a single transplant center.
We identified 14 pregnancies in 10 women who had undergone liver transplantation (12 childbirths, one induced abortion due to fetal death in the first trimester, one pregnancy is still ongoing). Causes of transplantation include congenital or acquired disorders and the most common indication was autoimmune hepatitis (50%). The mean age at the point of transplantation was 28.5 (range 21-36), mean maternal age at pregnancy was 32 (range 26-43), and transplant-to-pregnancy interval was 4.07 years (range 1.5-7). The mean gestational week was 36.67 (range 31-40). Immunosuppression was maintained with combinations of prednisone (n = 11), tacrolimus (n = 13), and azathioprine (n = 8) prior to and during pregnancy. Two pregnancies were unintended, so women took mycophenolate mofetil in the first weeks of gestation. Another two women stopped taking azathioprine due to increasing anemia. Maternal complications included increase of aspartate transaminase and alanine transaminase (n = 2), anemia (n = 4) and hyperthyroidism (n = 2). Among the 12 childbirths, five (41.67%) were preterm. Only five women entered labor spontaneously, while seven (58,33%) had cesarean delivery.
Pregnancy after liver transplantation can achieve relatively favorable outcomes. Liver transplantation does not influence women's fertility and, during pregnancy, we report low rates of minor graft complications. A multidisciplinary team should be involved in contraceptive, fertility and consequently pregnancy counseling of female transplant recipients.
肝移植是一种挽救生命且成功的治疗方法,在全球范围内越来越频繁,其中也包括育龄妇女。因此,越来越多的报告显示肝移植后怀孕,但对于孕前咨询和妊娠管理的最佳方法仍存在疑问。本研究旨在报告和评估接受肝移植的女性的妊娠结局。
我们回顾性分析了在单一移植中心接受医疗护理并报告怀孕的女性肝移植患者。
我们在 10 名接受肝移植的女性中发现了 14 例妊娠(12 例分娩,1 例因孕早期胎儿死亡而人工流产,1 例仍在继续妊娠)。移植的原因包括先天性或获得性疾病,最常见的指征是自身免疫性肝炎(50%)。移植时的平均年龄为 28.5 岁(范围 21-36 岁),妊娠时的平均年龄为 32 岁(范围 26-43 岁),移植至妊娠的间隔为 4.07 年(范围 1.5-7 年)。平均妊娠周数为 36.67 周(范围 31-40 周)。在怀孕前和怀孕期间,免疫抑制采用泼尼松(n=11)、他克莫司(n=13)和硫唑嘌呤(n=8)联合用药。有两例妊娠是意外妊娠,因此孕妇在妊娠早期使用了霉酚酸酯。另外两名女性因贫血而停用硫唑嘌呤。母亲的并发症包括天冬氨酸转氨酶和丙氨酸转氨酶升高(n=2)、贫血(n=4)和甲状腺功能亢进(n=2)。在 12 例分娩中,有 5 例(41.67%)早产。只有 5 名妇女自然分娩,而 7 名(58.33%)进行了剖宫产。
肝移植后妊娠可获得相对良好的结局。肝移植不会影响女性的生育能力,在怀孕期间,我们报告肝移植并发症发生率较低。应多学科团队应参与女性移植受者的避孕、生育和妊娠咨询。